Skip to content

A study on the efficacy of IPSRT in the treatment of depression with biological rhythm disorder

A study on the efficacy of IPSRT in the treatment of depression with biological rhythm disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116865
Enrollment
Unknown
Registered
2026-01-15
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression with biological rhythm disorder

Interventions

Experimental group:Provide weekly sessions of 45-minute IPSRT treatment for a duration of 12 weeks.
Control group:Provide weekly health education on sleep hygiene for 20 minutes, along with guidance on sleep behaviors.

Sponsors

The First People's Hospital of Hangzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18 - 65 years old; 2. Meets the clinical diagnostic criteria for major depressive episode as per DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition); 3. HDRS-17 (Hamilton Depression Scale 17 items) > 17 points; 4. Total score of Pittsburgh Sleep Quality Index (PSQI) >= 7 points; 5. Neuro-psychiatric biological rhythm assessment interview >= 29 points; 6. No medication treatment received; 7. All patients and their families gave informed consent for this study;

Exclusion criteria

Exclusion criteria: 1. Individuals with other DSM-5 spectrum disorders; 2. Mental disorders caused by substance abuse (alcohol, drugs, etc.); 3. Those with severe physical illnesses; 4. Those who have received drug treatment within the last 3 months before enrollment (such as antidepressants, antipsychotic drugs, sedative-hypnotic drugs, etc.); 5. Those who currently have serious suicidal thoughts or behaviors (MADRS (Montgomery-Asberg Depression Scale) item 10 on suicidal ideation >= 4 points), or those with severe agitation; 6. Those who have received electroconvulsive therapy within the last month; 7. Those who have participated in other clinical trials of investigational drugs within the past 60 days;

Design outcomes

Primary

MeasureTime frame
Sleep quality;Depressive symptoms;Sleep phase monitoring;Biological rhythm;

Countries

China

Contacts

Public ContactChunxiao Dai

The First People's Hospital of Hangzhou

janedcx@163.com+86 571 5600 6902

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026